Company intelligence
Curapath
Leading Next Generation Non-viral Gene Delivery to Improve People´s Lives
About Curapath
Curapath, is a global CDMO specialized in the tailored design, development, and GMP manufacturing of cutting-edge polymer and lipid-based drug delivery systems. Our customers benefit from our unique expertise, operational excellence and technical solutions in polymer nanoparticles (PNPs) and lipid nanoparticles (LNPs) along with their essential components. In addition, we have extensive experience in drug conjugation and cross-linking, to increase stability, reduce toxicity, and enhance bioactivity. At Curapath, we stand as your partner from discovery stages to commercial GMP scale-up. With our dedicated support, expertise, and state of the art manufacturing capabilities, we assure you a guaranteed path for your drug to navigate through clinical development and reach commercialization seamlessly Your success is our commitment
Verified activity
Signals from Curapath
4 published signals
Research & Knowledge
Curapath published a new article exploring the challenges of choosing the drug delivery vehicle for therapy through LNPs and PNPs.
Reported by Curapath
Presence & Recognition
Curapath is presenting a team representing the company in Milan, featuring Elena Gallon, Rafael Miravet Martí, Miguel Ángel Esteve, Carles Felip León, Victor R. de la Rosa, and Philippe Clavel.
Reported by Curapath
Products & Services
Curapath added a new product page for Poly-L-Arginine and Polypeptoids to its Polyamino Acids and Polypeptoids section.
Reported by Curapath
Products & Services
Curapath launched new product pages featuring strong science, high-performing products, and easier access to materials for researchers across industry and academia.
Reported by Philippe Clavel